Gregory Berk

Chief Medical Officer, Talon Therapeutics, Inc.

Companies

GT Biopharma, Inc.Pres. of R&D, CMO Jul 19, 2022 to Jul 19, 2022¹
GT Biopharma, Inc.Board member Feb 14, 2022 to Feb 14, 2022²
Verastem OncologyChief Medical Officer Apr 19, 2016 to Jan 11, 2017³
Astex PharmaceuticalsChief Medical Officer May 30, 2007 to Mar 16, 2009⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

GT Biopharma, Inc. GTBP278,058 shares⁵$2.0M at $7.36Feb 16, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 16, 2021Granted 278,058 shares of GT Biopharma, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARGT Biopharma, Inc., Pres. of R&D, CMO
2
SEC EDGARGT Biopharma, Inc., Board member
3
SEC EDGARVerastem Oncology, Chief Medical Officer
4
SEC EDGARAstex Pharmaceuticals, Chief Medical Officer
5
SEC EDGARGT Biopharma, Inc. shares after the filing of Feb 16, 2021